ID: ALA3660161

Max Phase: Preclinical

Molecular Formula: C9H14N4O2

Molecular Weight: 210.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)n1cc2c(n1)N(O)C(=O)[C@@H](N)C2

Standard InChI:  InChI=1S/C9H14N4O2/c1-5(2)12-4-6-3-7(10)9(14)13(15)8(6)11-12/h4-5,7,15H,3,10H2,1-2H3/t7-/m0/s1

Standard InChI Key:  GXFHBMAGBQZBDV-ZETCQYMHSA-N

Associated Targets(Human)

Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial 207 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.24Molecular Weight (Monoisotopic): 210.1117AlogP: 0.07#Rotatable Bonds: 1
Polar Surface Area: 84.38Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.07CX Basic pKa: 8.07CX LogP: -0.62CX LogD: -0.55
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.64Np Likeness Score: -0.33

References

1.  (2013)  KAT II inhibitors, 
2.  (2015)  KAT II inhibitors, 

Source

Source(1):